Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (71-80 of 405) with videos related to

Pageof 41
Sort By:
Journal of Pediatric Orthopedics|January 28, 2006
Pediatric olecranon fractures: open reduction and internal fixation with removable Kirschner wires and absorbable suturesYair Gortzak, Eyal Mercado, Dan Atar, et al.
Pharmacology & Therapeutics|May 20, 2014
Current role of neprilysin inhibitors in hypertension and heart failureThomas G von Lueder, Dan Atar, Henry Krum
Cardiology|February 1, 2007
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patientsVictor L Serebruany, Alex I Malinin, Dan Atar
Journal of Thrombosis and Thrombolysis|May 29, 2007
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular diseaseVictor L Serebruany, Alex Malinin, Stephen Ong, et al.
Acute Cardiac Care|July 9, 2008
Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysisLene Helleskov Madsen, Søren Ladefoged, Per Hildebrandt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2019
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapySverre E Kjeldsen, Dan Atar, Thomas G von Lueder
Journal of Cardiac Failure|March 9, 2010
COPD predicts mortality in HF: the Norwegian Heart Failure RegistryJonathan De Blois, Serge Simard, Dan Atar, et al.
Thrombosis and Haemostasis|December 22, 2011
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrelDániel Aradi, Wiktor Kuliczkowski, Dan Atar, et al.
Journal of Cardiovascular Pharmacology|November 2, 2020
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysisMuhammad H Maqsood, Mahboob Alam, Dan Atar, et al.
Cardiology|May 19, 2026
Main Lessons of the Recent Andexanet WithdrawalPierre Sabouret, Dan Atar, Marco Bernardi, et al.
Pageof 41

Showing results (71-80 of 405) with videos related to

Sort By:
Pageof 41
Journal of Pediatric Orthopedics|January 28, 2006
Pediatric olecranon fractures: open reduction and internal fixation with removable Kirschner wires and absorbable suturesYair Gortzak, Eyal Mercado, Dan Atar, et al.
Pharmacology & Therapeutics|May 20, 2014
Current role of neprilysin inhibitors in hypertension and heart failureThomas G von Lueder, Dan Atar, Henry Krum
Cardiology|February 1, 2007
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patientsVictor L Serebruany, Alex I Malinin, Dan Atar
Journal of Thrombosis and Thrombolysis|May 29, 2007
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular diseaseVictor L Serebruany, Alex Malinin, Stephen Ong, et al.
Acute Cardiac Care|July 9, 2008
Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysisLene Helleskov Madsen, Søren Ladefoged, Per Hildebrandt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2019
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapySverre E Kjeldsen, Dan Atar, Thomas G von Lueder
Journal of Cardiac Failure|March 9, 2010
COPD predicts mortality in HF: the Norwegian Heart Failure RegistryJonathan De Blois, Serge Simard, Dan Atar, et al.
Thrombosis and Haemostasis|December 22, 2011
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrelDániel Aradi, Wiktor Kuliczkowski, Dan Atar, et al.
Journal of Cardiovascular Pharmacology|November 2, 2020
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysisMuhammad H Maqsood, Mahboob Alam, Dan Atar, et al.
Cardiology|May 19, 2026
Main Lessons of the Recent Andexanet WithdrawalPierre Sabouret, Dan Atar, Marco Bernardi, et al.
Pageof 41